Designation: Professor
Department: Department of Gastroenterology
University: The 309th Hospital of the People's Liberation Army
Country: China
Bo Jin has completed his MD from Second Military Medical University, Shanghai, China. He completed his Master of Science from Graduate School of Medicine of PLA, Beijing, China. He received his Ph.D. from the Department of Gastroenterology at Graduate School of Medicine of PLA in 2005 in China. He is currently working as a professor of Department of Gastroenterology at the 309th Hospital of the People's Liberation Army, Beijing, China. He attended many international conferences. He published articles in many national and international journals.
His research interest mainly focuses on immunology and liver fibrosis. My interests in liver fibrosis research focus on the use of intrahepatic administration of collagenase for reversal of liver fibrosis and this work was one of the earliest that established proof-of-principle of these potential therapeutic agents. My immunological interest lie with double-stranded RNA induced immune response and its potential application in anti-virus and/or anti-cancer immunotherapy.
Boffin Access Limited is committed to maintaining the integrity of the scholarly record to researchers. Therefore violation of professional ethical codes may lead to retract articles. Article(s) may be retracted if it is found to have serious flaws, reported misconduct research, constitute copyright infringement and plagiarism.
To help avoid the incorrect or misleading publications, please drop your message to
Send Information
Enter your e-mail address to stay informed about published articles, issue releases and latest updates on journal activities.
We openly welcome feedback and constructive criticism. Your compliments, concerns and suggestions regarding our services will prove enormously helpful in making them even better.
Do you have an idea or suggestion that can influence the Open Access community? Send an email to: support@boffinaccess.org
Copyright © 2020 Boffin Access Limited.